Amoxicillin NDC 62135-776

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-776Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0776Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62135-776-38	62135077638	150 mL in 1 BOTTLE (62135-776-38)Marketed from Dec 15, 2023
62135-776-42	62135077642	100 mL in 1 BOTTLE (62135-776-42)Marketed from Dec 15, 2023
62135-776-68	62135077668	80 mL in 1 BOTTLE (62135-776-68)Marketed from Dec 15, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Amoxicillin
Generic name (nonproprietary): amoxicillin
Active ingredients: Amoxicillin — 125 mg/5mL
Dosage form: Powder, For suspension
Route: Oral
Labeler: Chartwell RX, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 062059
Marketing start: Dec 8, 1978
Listing expires: Dec 31, 2026
Other FDA classes: Penicillins (Chemical structure)
Identifiers: Product ID 62135-776_4690a5fd-79cc-e1fd-e063-6294a90a009cSPL ID 4690a5fd-79cc-e1fd-e063-6294a90a009cSPL set ID 9ce26893-c7a1-47e9-98f9-f5d998cac418RxCUI 239191, 313797UNII 804826J2HUUPC 0362135776381, 0362135777388
Pharmacologic class: Penicillin-class Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135077638 followed by a unit qualifier and the quantity

Package 62135-0776-38. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 22, 2025.

Indications (excerpt from the label)

Adults and Pediatric Patients Upper Respiratory Tract Infections of the Ear, Nose, and Throat: Amoxicillin for oral suspension is indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Streptococcus species. (α-and β-hemolytic isolates only), Streptococcus pneumoniae , Staphylococcus spp., or Haemophilus influenzae . Infections of the Genitourinary Tract : Amoxicillin for oral suspension is indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Escherichia coli, Proteus mirabilis , or Enterococcus faecalis . Infections of the Skin and Skin Structure: Amoxicillin for oral suspension is indicated in the t…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 062059

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 062059
Product	Strength	Form · route	Labeler	Product NDC
Amoxicillin	Amoxicillin 250 mg/5mL	Powder, For suspensionOral	Chartwell RX, LLC	62135-777